Toward better drug discovery with knowledge graph
Related Experiment Video
Updated: Oct 16, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
Xiangxiang Zeng1, Xinqi Tu1, Yuansheng Liu1
1College of Information Science and Engineering, Hunan University, Changsha, 410086, China.
Abstract:
Drug discovery is the process of new drug identification. This process is driven by the increasing data from existing chemical libraries and data banks. The knowledge graph is introduced to the domain of drug discovery for imposing an explicit structure to integrate heterogeneous biomedical data. The graph can provide structured relations among multiple entities and unstructured semantic relations associated with entities. In this review, we summarize knowledge graph-based works that implement drug repurposing and adverse drug reaction prediction for drug discovery. As knowledge representation learning is a common way to explore knowledge graphs for prediction problems, we introduce several representative embedding models to provide a comprehensive understanding of knowledge representation learning.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug-Receptor Bonds
In...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Ogive Graph
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

